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Abstract
In order to elucidate the role of erythrocyte catalase in the accumulation of mercury in ery-
throcytes, labeled erythrocytes and plasma were prepared by exposing normal and acatalasemic
mice to radioactive mercury vapor (203Hg0: 6.8mg/m3) for 30 min. Labeled erythrocytes (or
plasma) were mixed with unlabeled plasma (or erythrocytes) of normal or acatalasemic mice and
incubated at 0 degrees C for 1 h. After incubation, the radioactivity of mercury in the erythro-
cytes and the plasma was measured by a gammascintillation counter. When labeled erythrocytes
were incubated with unlabeled plasma, the ratio of mercury transferred from acatalasemic erythro-
cytes to normal plasma (11.6%) or to acatalasemic plasma (13.3%) were significantly higher than
that from normal erythrocytes to normal plasma (1.8%) or to acatalasemic plasma (2.2%). When
labeled normal (or acatalasemic) plasma was incubated with unlabeled normal or acatalasemic
erythrocytes, the uptake of mercury by acatalasemic erythrocytes from normal plasma was 2.0%,
and 1.2% from acatalasemic plasma, which tended to be lower than that by normal erythrocytes
from normal plasma (3.4%) or from acatalasemic plasma (2.2%). The results indicated impaired
accumulation of mercury in acatalasemic erythrocytes, suggesting the importance of catalase in
taking up mercury in erythrocytes and protecting other organs from toxic effects of metallic mer-
cury.
KEYWORDS: mercury, catalase, acatalasemia, erythrocytes, biological monitoring
∗PMID: 1575060 [PubMed - indexed for MEDLINE]
Copyright (C) OKAYAMA UNIVERSITY MEDICAL SCHOOL
1Yamamoto et al.: Impaired in vitro accumulation of mercury in erythrocytes of
Produced by The Berkeley Electronic Press, 1992
2Acta Medica Okayama, Vol. 46 [1992], Iss. 2, Art. 2
http://escholarship.lib.okayama-u.ac.jp/amo/vol46/iss2/2
3Yamamoto et al.: Impaired in vitro accumulation of mercury in erythrocytes of
Produced by The Berkeley Electronic Press, 1992
4Acta Medica Okayama, Vol. 46 [1992], Iss. 2, Art. 2
http://escholarship.lib.okayama-u.ac.jp/amo/vol46/iss2/2
5Yamamoto et al.: Impaired in vitro accumulation of mercury in erythrocytes of
Produced by The Berkeley Electronic Press, 1992
6Acta Medica Okayama, Vol. 46 [1992], Iss. 2, Art. 2
http://escholarship.lib.okayama-u.ac.jp/amo/vol46/iss2/2
7Yamamoto et al.: Impaired in vitro accumulation of mercury in erythrocytes of
Produced by The Berkeley Electronic Press, 1992
